p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma

Gastroenterology

Volumn 116, Issue 2, 1999, Pages 394-400

  Matsuda, Y ^a   Ichida, T ^a   Matsuzawa, J ^a   Sugimura, K ^a   Asakura, H ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0032924622     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70137-X     Document Type: Article

References (26)

1. T Nobori K Miura DJ Wu A Lois K Takabayashi DA. Carson Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature 368 1994 753 756
2. A Kamb NA Gruis J Weaver-Feldhaus Q Liu K Harshman SV Tavtigian E Stockert RS Day 3rd BE Johnson MH. Skolnick A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
3. INK4 in hepatocellular carcinoma Hepatology 24 1996 575 579
4. INK4A gene in liver cancer Int J Cancer 67 1996 176 180
5. KIP2 genes in hepatocellular carcinoma Int J Oncol 12 1998 583 588
6. K Biden J Young R Buttenshaw J Searle G Cooksley DB Xu B. Leggett Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population Hepatology 25 1997 593 597
7. A Merlo JG Herman L Mao DJ Lee E Gabrielson PC Burger SB Baylin D. Sidransky 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 1995 686 692
8. M Gonzalez-Zulueta CM Bender AS Yang T Nguyen RW Beart JM Van Tomout PA. Jones Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing Cancer Res 55 1995 4531 4535
9. CL. Hsieh Dependent of transcriptional repression on CpG methylation density Mol Cell Biol 14 1994 5487 5494
10. INK4A in archival human solid tumors: correlation with retinoblastoma protein expression Cancer Res 55 1995 6006 6011
11. A Bobba R Lippolis S Giannattasio C Camaschella E. Marra An efficient method for PCR analysis of mitochondrial DNA from paraffin-embedded archival heart tissue PCR Methods Appl 4 1995 309 310
12. DG Walker W Duan EA Popovic AH Kaye FH Tomlinson M. Lavin Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas Cancer Res 55 1995 20 23
13. K Ueki Y Ono JW Henson JT Efird A von Deimling DN. Louis CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 1996 150 153
14. JG Herman JR Graff S Myohanen BD Nelkin SB. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 1996 9821 9826
15. ML Gonzalgo PA. Jones Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE) Nucl Acids Res 25 1997 2529 2531
16. P Cairns L Mao A Merlo DJ Lee D Schwab Y Eby K Tokino P Riet JE Blangrund D. Sidransky Rates of p16(MTS1) mutations in primary tumors with 9p loss Science 265 1994 415 417
17. SY Zhang AJ Klein-Szanto ER Sauter M Shafarenko S Mitsunaga T Nobori DA Carson JA Ridge TL. Goodrow Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck Cancer Res 54 1994 5050 5053
18. Z Piao C Park JS Lee CH Yang KY Choi H. Kim Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma Cancer Lett 122 1998 201 207
19. LX Qin ZY Tang KD Liu SL Ye B He Y Zhang G. Zhou Alterations of CDKN2 (p16/MTS1) exon 2 in human hepatocellular carcinoma Oncol Rep 3 1996 405 408
20. INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma Hepatology 25 1997 1376 1381
21. M Gonzalgo C Bender E You M Glendening J Flores G Walker N Hayward P Jones J. Fountain Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors Cancer Res 57 1997 5336 5347
22. RA. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
23. N Nishida Y Fukuda T Komeda R Kita T Sando M Furukawa M Amenomori I Shibagaki K Nakao M Ikenaga K. Ishizaki Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma Cancer Res 54 1994 3107 3110
24. YJ Zhang W Jiang CJ Chen CS Lee SM Kahn RM Santella IB. Weinstein Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma Biochem Biophys Res Commun 196 1993 1010 1016
25. Y Murakami K Hayashi S Hirohashi T. Sekiya Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas Cancer Res 51 1991 5520 5525
26. P. Jones DNA methylation errors and cancer Cancer Res 56 1996 2463 2467